Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

SZSE:300255 Stock Report

Market Cap: CN¥18.7b

Hebei Changshan Biochemical Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 300255?
Owner TypeNumber of SharesOwnership Percentage
Private Companies22,659,5002.47%
Institutions26,816,1602.92%
VC/PE Firms45,953,0205%
Individual Insiders342,101,43637.2%
General Public481,530,76252.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 47.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30.5%
Shu Gao
280,644,728CN¥5.7b0%no data
5%
SDIC Hi-tech Investment Co., Ltd
45,953,020CN¥933.3m0%10.19%
4.77%
Minghuan Yang
43,809,543CN¥889.8m-17.3%no data
2.47%
Hebei Huaxu Huagong Co., Ltd.
22,659,500CN¥460.2m0%no data
1.33%
Xi Chen
12,200,165CN¥247.8m0%no data
0.98%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
9,000,091CN¥182.8m0%0.01%
0.78%
JPMorgan Chase & Co, Brokerage and Securities Investments
7,202,590CN¥146.3m0%0.01%
0.43%
Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd.
3,975,600CN¥80.7m0%0.85%
0.38%
Goldman Sachs Group, Investment Banking and Securities Investments
3,500,000CN¥71.1m0%no data
0.32%
Hongshan Li
2,952,900CN¥60.0m0%no data
0.27%
The Vanguard Group, Inc.
2,453,293CN¥49.8m6.32%no data
0.17%
Xiaodong Gao
1,530,000CN¥31.1m0%no data
0.073%
Hao Cai
674,100CN¥13.7m0%no data
0.032%
Zhihua Li
290,000CN¥5.9m0%no data
0.03%
Dimensional Fund Advisors LP
274,786CN¥5.6m4.25%no data
0.029%
China Merchants Fund Management Company Ltd.
267,700CN¥5.4m0%no data
0.007%
Tianhong Asset Management Co., Ltd.
64,200CN¥1.3m0%no data
0.0051%
State Street Global Advisors, Inc.
47,000CN¥953.8k0%no data
0.0014%
China Universal Asset Management Company Ltd.
13,300CN¥270.7k0%no data
0.001%
E Fund Management Co., Ltd.
9,200CN¥186.7k0%no data
0.0006%
Harvest Fund Management Co. Ltd.
5,500CN¥112.0k0%no data
0.00044%
Guotai Asset Management Company Limited
4,000CN¥82.1k0%no data
0.0004%
Invesco Great Wall Fund Management Co. Ltd
3,700CN¥74.7k0%no data
0.00036%
GF Fund Management Co., Ltd.
3,300CN¥67.2k0%no data
0.00034%
China Asset Management Co. Ltd.
3,100CN¥63.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 20:35
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jing QiangChina International Capital Corporation Limited
Xiaoyan WangChina Minzu Securities
Hai Zhu PengHuatai Research